Blood-brain barrier (BBB) contributes to maintenance of brain homeostasis. Gut microbiome composition affected BBB development and expression of tight junction proteins in rodents. However, we still do not know if there's any direct effect of gut microbiol composition on BBB permeability and function in normal adult animals. In current study, we determined temporal and spatial change of BBB permeability in rhesus monkeys receiving either oral or intravenous amoxicillin-clavulanic acid (AC), by monitoring CSF/serum albumin ratio (AR) and the volume transfer constant (K trans ).
INTRODUCTION
Gut-brain axis, or microbiome-gut-brain axis, often refers to the sophisticated mutual interactions between gut microbiome and the central nervous system (CNS) [1] [2] [3] , which has been demonstrated in preclinical and clinical studies 4 . Changes in gut microbiota could influence gastrointestinal physiology as well as homeostasis of CNS 3 , although the exact mechanism has not yet been fully understood 5 .
Blood-brain barrier (BBB) serves as the main gatekeeper of the brain, regulating the passage of nutrients and regulatory molecules from the circulatory system and guarding the CNS from toxins and pathogens 6 . Weakened BBB integrity, or 'leaky BBB', significantly contributes to the progression of many neurodegenerative and psychological diseases, including stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease (AD), Parkinson's disease (PD), schizophrenia and autism spectrum disorder (ASD) 7-9 . However, mechanisms by which the BBB opens up differ in different pathophysiological conditions and remains elusive for the most part 10 .
A crucial role of gut microbiome and their metabolites in the formation of the BBB during embryonic and neonatal stage has been demonstrated in germ-free (GF) mice, in which the BBB is more permeable to macromolecules compared to conventionally raised animals 11 . This result, however, is contradictory to Leclercq et al, showing low-dose oral penicillin in early life of mice moderately upregulated proteins which may enhance the integrity of BBB, in hippocampus 12 . So far, no direct evidence of BBB disruption was ever documented. Effects of gut microbiol change on BBB permeability and thus CNS, and by what mechanisms these effects happen still remain inconclusive.
It has been established that antibiotic administration affects not only the pathogens to which they are directed but also the entire microbiota 13 . In current study, a clinical dose of amoxicillin-clavulanic acid (AC), which are the most commonly prescribed antibiotic combination to patients, was used either orally to induce gut microbiol change 14 or intravenously. A well-established longitudinally monitoring method for monkey BBB permeability 9 was adopted to monitor temporal and spatial changes of BBB permeability after AC administration, thus to explore effect of antibiotic-induced gut "dysbiosis" comparing to "homeostatic gut microbiol condition" on BBB permeability.
MATERIALS AND METHODS

Experimental Animals
Twenty-one adult, male rhesus monkeys, weighing 4-10 kg and aged 4-6 years, were provided by Sichuan Green-House Biotech Co., Ltd, Sichuan Province, China, 2 weeks prior to experiment, and were housed in separate cages and maintained in a 12-hour light/dark cycle at room temperature. All the experimental procedures were conducted in accordance with the Guidance Suggestions for the Care and Use of 
Antibiotic administration and sample collection
A total of 21 adult monkeys were randomized into 2 groups (Table 1 ). In oral AC group (n = 15), AC diluted in 10 ml of 5% dextrose solution were given orally twice a day for 14 days at 200 mg/28.5 mg/kg body weight, a dose commonly used in clinical practice. In intravenous AC group (n = 6), AC was given intravenously twice a day for 14 days at 6 mg/0.86 mg/kg body weight, leading to the C max of amoxicillin in blood similar to the orally administered AC. Fecal, cerebrospinal fluid (CSF), and blood samples were obtained before and after antibiotic exposure. All samples were stored at -80 until further analysis.
Serial CSF Sampling from Cisterna Magna
Minimally invasive catheterization to sample the CSF from monkey cisterna magna was performed as previously described 9 . For detailed information, see
The CSF/serum albumin ratio (AR) measurement
The CSF and serum albumin were measured by corresponding enzyme-linked immunosorbent assay (ELISA) (ab108788, abcam, USA) and colorimetric method respectively. AR = albumin in CSF (mg/L) / albumin in serum (g/L). The quality of CSF was assessed as described previously 9 . Considering the variance of normal level of AR among the animals, fold increase of AR was calculated to accurately indicate the permeability change of BBB.
DCE-MRI
Monkeys received dynamic contrast-enhanced scanning with 3.0T MRI (DCE-MRI, Magnetom Verio, Siemens Medical Solution, Germany) to further identify the pattern, especially the spatial distribution, of BBB permeability change at day 0, 4, 7, 14 and 21. Frontal cortex, white matter, caudate nucleus, thalamus, and hippocampus were selected as regions of interest (ROIs). Raw data were processed by Siemens Tissue 4D software. Extended Tofts model was chosen to calculate the K trans value (i.e., the volume transfer constant, which represents flow from the intravascular to the extravascular space). Fold increase of K trans was used to accurately represent the permeability change of BBB due to the variance of normal level of K trans .
16S rRNA gene sequence analysis
The 16S rRNA analyses were used to characterize the gut microbiome in each fecal sample. Microbial DNA was extracted from stool samples using the Fast DNA ® SPIN Kit for Soil (MP Biomedicals, USA) according to manufacturer's protocols (see supplementary methods for detail).
Gas chromatography analysis of short chain fatty acids (SCFAs)
Three types of SCFAs (acetic acid, propionic acid, and butyrate) in monkey fecal samples were quantified by gas chromatography (see supplementary methods for detail).
Statistical Analysis
All data were expressed as mean ± standard error of mean (SEM). All graphs were generated using GraphPad Prism software (version 7.0, San Diego, CA, USA).
The difference among the means of the groups was determined with the one-way ANOVA, followed by the Tukey test. Principal coordinates analysis (PCoA) of β -diversity analysis was performed to visualize the differences among gut microbiome.
Comparisons between values of each time point were performed with Student's t-test
or Mann Whitney U test depending on normality of distribution. All correlations were analyzed statistically by using Pearson's correlation. A p value of less than 0.05 was considered significant in all analysis.
RESULTS
Oral antibiotics led to reversible alterations of gut microbial composition
As shown in figure 1A , the trend of Rank-abundance distribution curve representing evenness and richness of bacterial community displayed significant differences between po. group and iv. group. In po. group, the richness and evenness of bacterial diversity decreased significantly during AC treatment and reached its trough 7 days after antibiotic administration (day 7). After cessation of AC, there was a general tendency towards the restoration to the original (day 0) microbiome composition. In contrast, intravenously treated monkeys barely showed variations of gut microbiome composition ( Fig. 1A inserted) . After oral AC medication, the α -diversity Shannon index decreased significantly from 4.14 ± 0.15 (day 0) to 1.52 ± 0.38 (day 7) (p < 0.001), indicating that there were fewer heterogeneously distributed bacterial families during the initial dosing period. Shannon index then began to increase slowly during the second half of AC medication period and the upward trend was more obvious after cessation of the AC treatment ( Fig. 1B) . However, the Shannon index was still significantly lower than that of day 0 (p = 0.010). Conversely, Shannon index remained stable in iv. group and no statistical differences were found among each time point ( Fig. 1B ).
PCoA analysis showed 89.66% and 4.65% of the total variance found could be explained by the first and second axis of the PCoA scatterplots, respectively.
Microbiomes at day 21 and day 0 were clustered together, while a clear separation were observed between the microbiota during dosing period and non-dosing period, which indicated oral AC medication induced a significantly reversible microbiol composition change. (Fig. 1C ).
The composition of microbe in phylum level was shown in Fig. 1D . At day 0, Firmicutes (51.71 ± 2.66%) and Bacteroidetes (39.25 ± 3.40%) were dominant members. In po. group, Firmicutes and Bacteroidetes decreased to 7.14 ± 2.82% (day 4), 8.09 ± 4.98% (day 1) respectively, while Proteobacteria phylum and Spirochaetae phylum increased from 2.48±1.04% (day 0) to 49.79±7.15 % (day 7), and 5.31±1.16% (day 0) to 28.70 ± 6.25 (day 1), respectively during dosing period. Seven days after AC withdrawal, the abundance of Firmicutes, Bacteroidetes, Proteobacteria and Spirochaetae mostly returned to their baseline levels. However, little change was found in iv. group during the whole experiment process.
Oral antibiotics led to increase of BBB permeability
Qualified CSF samples were successfully collected from 12 out of the 15 monkeys ( Table 1 ). AR increase fold elevated significantly to 1.26 ± 0.11 at day 1, and reached its peak of 1.44 ± 0.10 at day 4 in AC po. group (p = 0.030 compared to day 0). Thereafter, the level deceased gradually but remained relatively high compared with the baseline level during the remaining dosing period. Seven days after cessation of AC treatment, the fold increase of AR decreased to 1.06 ± 0.08 which approximately back to pre-antibiotics level ( Fig. 2A , black curve). In AC iv.
group, there was just a mild fluctuation of AR with no significant change ( Fig. 2A, red curve). In AC po. group, AR increased in every monkey during the dosing period, although the change pattern varied greatly among the animals (Suppl. Fig 2) .
Therefore, AR of pre-antibiotics value (day 0), maximal value, post-antibiotics value (day 21) and the corresponding Shannon index of each monkey were chosen for further correlation analysis. The Shannon index, as well as sobs and chao index, was significantly negatively correlated with the fold increase of AR (r = -0.575, p = 0.004; r = -0.587, p = 0.003; r = -0.531, p = 0.002, respectively Fig.2B -D).
BBB permeability increased most significantly at thalamus
After AC administration, a general upward tendency of K trans was observed in all five ROIs at different time points compared with that of day 0 ( Fig. 3 ), although the changing trends were completely discordant among the ROIs (Suppl. Fig 3) . There were no significant differences found in the K trans values of caudate nucleus, white matter, and hippocampus, although there was a consistent uptrend change in hippocampal area (p = 0.145, 0.179, 0.106, 0.060 at day 4, day 7, day 14 and day 21 respectively compared with day 0) throughout the experiment ( Fig. 3C-E) . Notably, in thalamus, the K trans value increased consistently and significantly during dosing period (p = 0.030, 0.003, 0.006 at day 4, day 7, and day 14 respectively compared with day 0) and this phenomenon was also observed at day 21 after cessation of the AC treatment (p = 0.022, Fig. 3F ). In addition, there was a statistically significant difference of the K trans value of frontal cortex between day 7 and day 0 (p = 0.013, Fig. 3G ).
Oral antibiotic treatment altered microbial metabolism
As SCFAs were shown to be a probable regulators of BBB integrity in germ-free mice 15 , level of the acetic acid, propionic acid and butyrate decreased significantly during dosing period (for acetic acid, p = 0.018, 0.030, 0.011 at day 1, day 4 and day 7 respectively compared with day 0; for propionic acid, p = 0.050, 0.026, 0.002, 0.010 at day 1, day 4, day 7 and day 14 respectively compared with day 0; for butyrate, p = 0.007, 0.022, 0.012 at day 1, day 4 and day 7 compared with day 0) and returned to baseline at day 21 after cessation of the AC (Fig. 4A) Fig. 4 ). Positive correlations were observed between three types of SCFAs (acetic acid, propionic acid and butyrate) concentration and relative abundance of the nine genera (r = 0.426, p = 0.001; r = 0.376, p = 0.005; r = 0.327, p to the fold increase of AR (r = -0.748, p = 0.005 and r = -0.681, p = 0.015, respectively, Fig. 4J, K) , while no significantly negative correlation was found between butyrate concentration and AR ( Fig. 4L ). Besides, we also evaluated the correlations between phylum Firmicutes, acetic acid, propionate acid, butyrate and the fold increase of K trans (hippocampus region and thalamus region). Negative correlation was found between relative abundance of phylum Firmicutes, acetic acid, propionic acid and the fold increase of K trans in the thalamus region, while only propionic acid was negatively correlated to the fold increase of K trans in the hippocampus region ( Supplementary table) .
DISCUSSION
Effect of gut microbiome on BBB has been controversial, with evidence showing abnormal BBB development and decreased level of occludin and claudin-5 mRNA in amygdala and hippocampus germ-free mice, while upregulated proteins Occludin and
Claudin-5 were seen in mice receiving low-dose oral penicillin in early life 11, 12 . To the best of our knowledge, this is the very first study to investigate on direct evidence of effects of gut microbiol alterations on BBB permeability and thus CNS.
In the current study, BBB permeability was determined using a standard method involving measuring AR, which was similar and comparable to the method used in current clinical practice. Although some techniques such as microdialysis could be used for rodent CSF sampling, it is only suitable for analysis of metal ions, neurotransmitters, and other small molecules, rather than protein analysis. Non-human primates are not only more translational relevant, it can provide as much as 800 μ L CSF at each sampling time point by using the minimally invasive catheterization method developed in our lab 9 , making it possible to measure AR and thus BBB permeability directly.
A drastic shift of the biodiversity and richness of gut microbiome was induced by oral AC treatment at a comparable dosage. Accordingly, BBB permeability determined by continuous AR and K trans increased significantly in oral, but not intravenous, AC treated animals. These findings suggested that antibiotics-induced gut microbiol composition change not only could affect CNS and BBB permeability, but also could affect them directly rather than through contact between blood and brain endothelium. Meanwhile, a healthy gut microbiome baseline and a reversion trend of BBB permeability change towards normal status after medication discontinuation was observed in healthy adult monkeys, indicating that BBB was under relatively normal physiological conditions before antibiotic treatment. These results might suggest a totally different BBB permeability disruption mechanism in adults, which might be more correlated with a direct gut microbiol composition alterations induced by antibiotics oral administration, comparing to BBB dysplasia before adulthood as previously reported 11 .
Antibiotics have been a pillar of modern medicine as a means to treat bacterial infections in humans and animals and have been widely used on an enormous scale around the world for almost a century 16 . Prophylactic treatment, including after stroke, has been one of the most frequent usage scenarios of antibiotics. As we previously reported, the extent of BBB permeability disruption was highly correlated to ischemic outcome in monkeys subjected to ischemic stroke 9 . Considering that only orally administrated AC interfered with gut microbiome and thus BBB permeability while intravenous AC achieving the same blood concentration did not, as presented in our results, it could be reasonable to speculate that intravenous prophylactic antibiotics sympathetic neural pathways and in the absence of any immune response, strongly suggesting a potential mechanism by which microbiome influence the BBB is by producing metabolites that can alter CNS function. SCFAs, such as butyrate, acetate, and propionate, produced through the fermentation of dietary fibers by the gut microbiota have been shown to improve BBB integrity in germ-free mice 15 . A recent report has shown the protective effects of propionate upon BBB endothelial cells against LPS-induced barrier disruption via a CD14-dependent mechanism 26 . In current study, SCFAs levels decreased significantly after AC treatment. This may result from the reduction in some SCFA-producing gut community members of SCFA-producing members. Besides, acetic acid and propionate acid were found to be correlated with AR while butyrate was not, which was different from germ-free mice 14 .
CONCLUSIONS
In conclusion, our study provides strong evidence that antibiotics-induced gut 
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